Detrol LA may interact with other anticholinergic agents found in some over-the-counter products (e.g., certain antihistamines). Combining them can increase the risk of dry mouth, constipation, and blurred vision. Discuss any additional bladder-related products with a pharmacist or clinician before use.
Both drugs belong to the anticholinergic class and reduce detrusor overactivity, but they differ in receptor selectivity and dosing frequency. Detrol LA is taken once daily as a 4 mg extended-release tablet, whereas solifenacin is usually prescribed once daily at 5 mg or 10 mg. Comparative efficacy and side-effect profiles should be evaluated by a prescriber based on individual patient factors.
Sudden urinary retention is a serious adverse event. Seek immediate medical attention; the prescriber may need to discontinue the medication and consider alternative therapies.
Yes, provided you carry the medication in its original packaging with the prescription label, and you have a copy of the prescription. Check the destination country’s regulations regarding personal import of prescription medicines, and keep the tablets in your carry-on luggage to avoid temperature extremes.
Tolterodine is classified as Category B3 in the UK, indicating limited data in human pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus, after a thorough discussion with a specialist obstetrician.
Anticholinergic drugs can cause mild tachycardia or changes in blood pressure, but significant hypertension is uncommon. Patients with uncontrolled hypertension should have their blood pressure monitored when starting therapy.
Dry mouth (xerostomia) is a common anticholinergic side effect caused by reduced saliva production. Sip water frequently, avoid caffeine and alcohol, and consider sugar-free lozenges or saliva substitutes if discomfort persists.
There is no direct interaction between tolterodine and dietary sodium. However, a low-salt diet may benefit overall cardiovascular health, which can be advantageous for patients with concomitant hypertension.
If you miss two or more consecutive doses, resume the regular once-daily schedule at the next planned dosing time. Do not attempt to “make up” missed doses, as this can increase side-effect risk.
Tolterodine is available as a generic medication in both immediate-release and extended-release forms. Generic versions contain the same active ingredient and are prescribed under the same dosing guidelines, though tablet appearance and inert ingredients may differ.
Detrol LA is a prescription medication used to treat symptoms of an overactive bladder. The active ingredient is tolterodine, an anticholinergic agent that reduces involuntary bladder contractions. Detrol LA is available in a 4 mg extended-release pill that is taken once daily. In the United Kingdom the product is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is classified as a prescription-only medicine (POM).
Tolterodine belongs to the antimuscarinic (anticholinergic) class of drugs. It blocks the action of acetylcholine at muscarinic receptors in the detrusor muscle of the bladder, mainly the M₂ and M₃ subtypes. By inhibiting these receptors, tolterodine reduces involuntary detrusor contractions, allowing the bladder to fill more fully before the urge to void occurs.
Key pharmacologic features:
Detrol LA is approved by the MHRA and EMA for the following indication:
The medication is intended for patients who have not achieved satisfactory control with behavioural therapies (e.g., bladder training) alone.
These effects are usually mild and tend to improve with continued therapy.
If any of these occur, discontinue the medication and seek urgent care.
Clinicians should review a full medication list, including over-the-counter and herbal products, before prescribing Detrol LA.
This article provides educational information about Detrol LA and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
